Calithera Biosciences Inc (CALA)

4.42 +0.03  +0.68% NASDAQ Apr 3, 20:00 Delayed 2m USD

Calithera Biosciences Total Liabilities (Quarterly):

26.34M for Dec. 31, 2019
View 4,000+ financial data types
View Full Chart

Total Liabilities (Quarterly) Chart

Export Data
Save Image
Print Image

Historical Total Liabilities (Quarterly) Data

View and export this data going back to 2013. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Dec. 31, 2019 26.34M
Sept. 30, 2019 25.66M
June 30, 2019 26.99M
March 31, 2019 25.93M
Dec. 31, 2018 16.01M
Sept. 30, 2018 11.76M
June 30, 2018 11.81M
March 31, 2018 30.72M
Dec. 31, 2017 42.15M
Sept. 30, 2017 47.45M
June 30, 2017 51.62M
March 31, 2017 58.18M
Dec. 31, 2016 4.89M
Sept. 30, 2016 5.113M
June 30, 2016 5.01M
March 31, 2016 4.294M
Dec. 31, 2015 3.962M
Sept. 30, 2015 5.935M
June 30, 2015 4.434M
March 31, 2015 3.769M
Dec. 31, 2014 4.404M
Sept. 30, 2014 74.66M
June 30, 2014 6.416M
Dec. 31, 2013 55.66M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.


Total Liabilities Definition

Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.

Read full definition.

Total Liabilities (Quarterly) Benchmarks

Intercept Pharmaceuticals Inc 703.33M
ACADIA Pharmaceuticals Inc 84.05M
Karyopharm Therapeutics Inc 245.19M

Total Liabilities (Quarterly) Range, Past 5 Years

Minimum 3.962M Dec 2015
Maximum 58.18M Mar 2017
Average 21.49M



Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{}} No credit card required.

Already a subscriber? Sign in.